Annual exports of individual pharmaceutical bio companies exceeded 2 trillion won. Last year, Samsung BioLogics recorded exports of 2.8 trillion won, up 2.3 times from the previous year, and Celltrion is also on the verge of achieving 2 trillion won. Of the 30 major listed biopharmaceutical companies, 24 showed an increase in export performance compared to the previous year. In addition to Samsung Biologics and Celltrion, ST Pharm, Ildong Pharm, Handok, HK Inno.N, and Daewoong are on the rise. According to the Financial Supervisory Service on the 3rd, the export performance of 30 major listed pharmaceutical companies in Korea last year was 7.3188 trillion won. Compared to 5.1946 trillion won in 2020, it increased by 37.4